| Literature DB >> 33507149 |
Dong Hyun Kim1, Hee Young Kim1,2,3, Sunjung Cho2, Su-Jin Yoo4, Won-Ju Kim5, Hye Ran Yeon6, Kyungho Choi6, Je-Min Choi5, Seong Wook Kang4, Won-Woo Lee1,2,3,7.
Abstract
Derived from a common precursor cell, the balance between Th17 and Treg cells must be maintained within immune system to prevent autoimmune diseases. IL-1β-mediated IL-1 receptor (IL-1R) signaling is essential for Th17-cell biology. Fine-tuning of IL-1R signaling is controlled by two receptors, IL-1RI and IL-RII, IL-1R accessory protein, and IL-1R antagonist. We demonstrate that the decoy receptor, IL-1RII, is important for regulating IL-17 responses in TCR-stimulated CD4+ T cells expressing functional IL-1RI via limiting IL-1β responsiveness. IL-1RII expression is regulated by NFAT via its interaction with Foxp3. The NFAT/FOXP3 complex binds to the IL-1RII promoter and is critical for its transcription. Additionally, IL-1RII expression is dysregulated in CD4+ T cells from patients with rheumatoid arthritis. Thus, differential expression of IL-1Rs on activated CD4+ T cells defines unique immunological features and a novel molecular mechanism underlies IL-1RII expression. These findings shed light on the modulatory effects of IL-1RII on Th17 responses.Entities:
Keywords: Foxp3; IL-1 receptor; IL-1β; NFAT; Th17; human; immunology; inflammation; rheumatoid arthritis (RA)
Mesh:
Substances:
Year: 2021 PMID: 33507149 PMCID: PMC7872515 DOI: 10.7554/eLife.61841
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140